Clinical trial
D3-GHR Polymorphism and Turner Syndrome
NCT00443144 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00443144 |
|---|---|
| Title | D3-GHR Polymorphism and Turner Syndrome |
| Official title | D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Turner Syndrome, Short Stature |
| Intervention type | Drug |
| Interventions | recombinant human growth hormone |
| Start date | May 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 5, 2007 |
| Last update posted | Dec 3, 2015 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: